{"name":"Aurinvest","permalink":"aurinvest","crunchbase_url":"http://www.crunchbase.com/financial-organization/aurinvest","homepage_url":"http://www.aurinvest.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"contact@aurinvest.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Apr 13 10:55:30 UTC 2010","updated_at":"Wed Sep 01 19:47:01 UTC 2010","overview":"<p>AURINVEST, development capital company, since November 2001 includes sixty actors of economic life around Michel Demont, its president.</p>\n\n<p>The CRA has invested over the past seven years in business-related sectors of activity known to members of the Investment Committee and in which there are opportunities for external growth.</p>\n\n<p>Most of these investments have been conducted jointly with the investment fund partners.</p>\n\n<p>The investments are subject to auditing and legal prior to issuing a letter of intent. Each of the entries is supervised by two particular members of the Investment Committee which shall report at the weekly meeting.</p>\n\n<p>The planned disposal of equity and included in shareholders&#8217; agreements are a period of four years maximum. The first release took place in 2004.</p>","image":{"available_sizes":[[[150,38],"assets/images/resized/0008/3609/83609v1-max-150x150.jpg"],[[250,63],"assets/images/resized/0008/3609/83609v1-max-250x250.jpg"],[[450,115],"assets/images/resized/0008/3609/83609v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"","address2":"","zip_code":"75008","city":"Paris","state_code":null,"country_code":"FRA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1100000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":20,"company":{"name":"CONEXANCE MD","permalink":"conexance-md","image":{"available_sizes":[[[150,38],"assets/images/resized/0008/3604/83604v1-max-150x150.jpg"],[[250,63],"assets/images/resized/0008/3604/83604v1-max-250x250.jpg"],[[385,98],"assets/images/resized/0008/3604/83604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":5330000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":1,"company":{"name":"Sinequa","permalink":"sinequa","image":{"available_sizes":[[[150,26],"assets/images/resized/0008/4391/84391v1-max-150x150.jpg"],[[223,39],"assets/images/resized/0008/4391/84391v1-max-250x250.jpg"],[[223,39],"assets/images/resized/0008/4391/84391v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/pharnext-sas-series-a-58m/","source_description":"Pharnext, SAS: Series A $5.8M","raised_amount":5800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":14,"company":{"name":"Pharnext","permalink":"pharnext","image":{"available_sizes":[[[150,35],"assets/images/resized/0009/0775/90775v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0009/0775/90775v1-max-250x250.jpg"],[[327,78],"assets/images/resized/0009/0775/90775v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":3240000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":19,"company":{"name":"Anaconda Pharma","permalink":"anaconda-pharma","image":{"available_sizes":[[[150,70],"assets/images/resized/0010/9112/109112v1-max-150x150.png"],[[178,84],"assets/images/resized/0010/9112/109112v1-max-250x250.png"],[[178,84],"assets/images/resized/0010/9112/109112v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}